Company intelligence / Profile preview
Hong Kong Universal Biologicals Company Limited
Hong Kong, Hong Kongconvention.bio.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
HKUBio has developed a proprietary live attenuated influenza viral vector vaccine platform enabling intranasal vaccines against major respiratory viruses. The technology underpinned collaborative efforts that led to approval of the world’s first intranasal COVID‑19 vaccine for emergency use in mainland China. The company is advancing a pipeline including seasonal flu, avian flu H5N1, RSV, bivalent flu-COVID vaccines, and gene delivery systems targeting lung cancer. Their approach aims to provide broad-spectrum mucosal immunity superior to traditional injectable vaccines.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Live attenuated viral vectorsGene delivery systems
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Xiamen UniversityBeijing Wantai BiopharmCentre for Virology, Vaccinology and Therapeutics (CVVT)
Beyond the preview
Go deeper on Hong Kong Universal Biologicals Company Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hong Kong Universal Biologicals Company Limited.